David Terrano(@david_terrano) 's Twitter Profileg
David Terrano

@david_terrano

Dermatopathologist and Medical Director. Trained scientist. Raised in Northfield, Ohio. Tweets my own.

ID:1013515226

calendar_today15-12-2012 16:24:01

16,3K Tweets

2,4K Followers

848 Following

David Terrano(@david_terrano) 's Twitter Profile Photo

Say it again Andrew Bellizzi 🇺🇦. I do love IHC though…appropriate and minimal rule-in and rule-out application is still a target goal of mine. Getting there slowly…

account_circle
Murali Varma(@MuraliV72899596) 's Twitter Profile Photo

Matthew Wasco This change is so unecessary. Rationale is to improve uptake of AS. In the UK, 95% of low risk 3+3 patients are managed with AS (compared to <50% in USA) largely thanks to our excellent cancer nurses. Better patient education is better than confusing nomenclature change.

account_circle
David Terrano(@david_terrano) 's Twitter Profile Photo

Looking at this again with the messy architecture and supportive, diffusely + PRAME, why is this not Melanoma in situ? It’s good to come back to it later. I remain convinced.

account_circle